ALXO Q1 2024 Earnings — ALX Oncology Holdings Inc. Revenue & Financial Results | Market Cap Arena

ALXOALX Oncology Holdings Inc.

$112M

Q1 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$214,000

Operating Income

-$38M

Net Income

-$36M

EPS (Diluted)

$-0.71

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$38M

Free Cash Flow

-$38M

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$213M

Total Liabilities

$48M

Stockholders' Equity

$164M

Cash & Equivalents

$14M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$214,000	$0	—
Operating Income	-$38M	-$32M	-17.3%
Net Income	-$36M	-$30M	-17.9%